Biotech investors in Europe
Updated 16 Nov 2026
Venture funds
25 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Innovate UK Innovate UK runs funding competitions for businesses and research organizations in emerging technologies, with recent awardees including Ryft and Concretene. Swindon, United Kingdom |
Artificial intelligence, Health care | 75% | 8 | |
| 2 | HTGF (High-Tech Gruenderfonds) HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate. Bonn, Germany |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 28% | 5 |
| 3 | Novo Holdings Novo Holdings invests in life science companies, with recent companies including Claris Biotherapeutics and Windward Bio. Hellerup, Denmark |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 36% | 4 |
| 4 | Sofinnova Partners Sofinnova Partners invests in life sciences from seed to later stage, including T-Therapeutics, Mironid and DISCO Pharmaceuticals. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 44% | 4 |
| 5 | BlueYard Capital BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio. Berlin, Germany |
Fintech, Biotech | Seed, Early stage venture | 41% | 3 |
| 6 | Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix. Ingelheim Am Rhein, Germany |
Biotech, Health care | Seed, Early stage venture | 47% | 3 |
| 7 | Hummingbird Ventures Hummingbird Ventures backs outlier founders globally, recently investing in Etched and Lovable. Brussels, Belgium |
Artificial intelligence, Biotech | Seed, Early stage venture | 28% | 3 |
| 8 | Astanor Ventures Astanor Ventures backs entrepreneurs regenerating food, the blue ocean economy and agriculture, with recent companies BioFluff and Standing Ovation. Luxembourg, Belgium |
Artificial intelligence, Biotech | Seed, Early stage venture, Late stage venture | 55% | 2 |
| 9 | Breakthrough Energy Ventures Breakthrough Energy Ventures targets reliable, affordable power without climate impact, recently backing Type One Energy and Antora Energy. Paris, France |
Energy, Artificial intelligence | Seed, Early stage venture, Late stage venture | 43% | 2 |
| 10 | Cambridge Innovation Capital Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica. Cambridge, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 36% | 2 |
| 11 | Dementia Discovery Fund Dementia Discovery Fund invests exclusively in novel dementia therapeutics, with recent investments in Alchemab Therapeutics and Cerevance. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 42% | 2 |
| 12 | Andera Partners Andera Partners makes early- and late-stage venture investments, with recent companies including Kainova Therapeutics and Exciva. Paris, France |
Biotech, Health care | Early stage venture, Late stage venture | 40% | 2 |
| 13 | Exceptional Ventures Exceptional Ventures focuses on early-stage entrepreneurs and businesses that improve people's lives, and recently backed Sava Technology and Amatera. London, United Kingdom |
Health care, Biotech | Seed, Early stage venture | 8% | 2 |
| 14 | Forbion Capital Partners Forbion Capital Partners makes private equity and venture capital investments in buyouts, with recent investments in Kynexis and Beacon Therapeutics. Naarden, The Netherlands |
Biotech, Health care | Seed, Early stage venture | 49% | 2 |
| 15 | Future Planet Capital London, United Kingdom |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 3% | 2 |
| 16 | Industrifonden Industrifonden invests in early-stage technology and life science companies with international potential, including Pixelgen Technologies and Cellevate. Stockholm, Sweden |
Hardware, Biotech | Seed, Early stage venture | 38% | 2 |
| 17 | Medicxi Medicxi focuses on life sciences, with recent companies Vaderis Therapeutics and D3 Bio. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 54% | 2 |
| 18 | M Ventures M Ventures invests in technologies relevant to Merck's core business areas, with recent investments including Neurable and Quintessent. Amsterdam, The Netherlands |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 37% | 2 |
| 19 | Metaplanet Metaplanet invests across diversified sectors, with recent companies including bit.bio, xCures and Neurable. Tallinn, Estonia |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 13% | 2 |
| 20 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
| 21 | Nucleus Capital Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia. Berlin, Germany |
Biotech, Health care | Seed, Early stage venture | 32% | 2 |
| 22 | Octopus Ventures Octopus Ventures supports companies from idea conception to IPO, including Living Optics and Edgify. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 54% | 2 |
| 23 | Seventure Partners Seventure Partners targets Tech/Digital and Life Sciences companies, with recent companies including Microbiotica and Standing Ovation. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 36% | 2 |
| 24 | SoftBank Vision Fund SoftBank Vision Fund makes growth capital and social impact investments, with recent companies including WHOOP and Opentrons. London, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 71% | 2 |
| 25 | XTX Ventures XTX Ventures invests in startups applying machine learning, recently backing CloudNC and Qureight. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture | 22% | 2 |
Table 1. Biotech investors in Europe: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | •••@htgf.de | +49 22••• |
| Venture Kick | Startup incubator | Schlieren, Switzerland | •••@venturekick.ch | +41 (2••• |
| Innovate UK | Entrepreneurship program | Swindon, United Kingdom | •••@innovateuk.ukri.org | |
| Bpifrance | Government investment office | Maisons-alfort, France | •••@bpifrance.fr | +33 (0••• |
| Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | •••@forbion.com | +31 35••• |
| Novo Holdings | Corporate venture arm | Hellerup, Denmark | •••@novo.dk | 45 35 ••• |
| KfW | Government investment office | Frankfurt, Germany | •••@kfw.de | 49 69 ••• |
| Sofinnova Partners | Venture capital firm | Paris, France | •••@sofinnovapartners.com | +33 (0••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 209 of the 283 biotech investors in Europe have a published email address, 174 a phone number and 282 a website.
- HTGF (High-Tech Gruenderfonds) has the most recorded investments, 1,026, 290 of them as lead investor.
- 189 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Innovate UK is an investor in 27 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 6,132 portfolio companies (73%).
- Early stage venture is the most common investment stage, recorded for 251 of them (89%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Europe
30 of 283, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | Biotech, Health care | Rabot Energy, CereGate, syte | 17 | 1,026 | 290 | 136 | •••@htgf.de | +49 22••• | In the CSV |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | Health care, Biotech | UniSieve, Cotierra, Jaipur Robotics | 13 | 1,459 | 1,342 | 82 | •••@venturekick.ch | +41 (2••• | In the CSV |
| 3 | Innovate UK | Entrepreneurship program, Venture capital firm | Swindon, United Kingdom | Artificial intelligence, Health care | Bioliberty, Concretene, Doctoria LTD | 27 | 1,307 | 976 | 84 | •••@innovateuk.ukri.org | In the CSV | |
| 4 | Bpifrance | Government investment office, Investment bank | Maisons-alfort, France | Artificial intelligence, Hardware | WORMSENSING, CarbonFarm Technology, Archeon | 19 | 1,680 | 454 | 214 | •••@bpifrance.fr | +33 (0••• | In the CSV |
| 5 | European Innovation Council | Startup accelerator | Brussels, Belgium | Hardware, Health care | Onego Bio, Quantrol Ox, Cellbox Solutions | 17 | 1,271 | 921 | 48 | In the CSV | ||
| 6 | Forbion Capital Partners | Private equity firm, Venture capital firm | Naarden, The Netherlands | Biotech, Health care | Kynexis, Beacon Therapeutics | 2 | 188 | 93 | 54 | •••@forbion.com | +31 35••• | In the CSV |
| 7 | Novo Holdings | Corporate venture arm, Venture capital firm | Hellerup, Denmark | Health care, Biotech | Claris Biotherapeutics, Windward Bio, Terremoto Biosciences | 5 | 417 | 150 | 115 | •••@novo.dk | 45 35 ••• | In the CSV |
| 8 | KfW | Government investment office, Investment bank | Frankfurt, Germany | Biotech, Health care | CryoTherapeutics, Vectoflow, HelloDuty | 198 | 29 | 56 | •••@kfw.de | 49 69 ••• | In the CSV | |
| 9 | Sofinnova Partners | Venture capital firm | Paris, France | Biotech, Health care | T-Therapeutics, Mironid, Bon Vivant | 5 | 373 | 164 | 76 | •••@sofinnovapartners.com | +33 (0••• | In the CSV |
| 10 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | Health care, Biotech | FoRx Therapeutics | 1 | 198 | 74 | 55 | •••@lspvc.com | +31 20••• | In the CSV |
| 11 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 12 | Andera Partners | Private equity firm, Venture capital firm | Paris, France | Biotech, Health care | Kainova Therapeutics, Exciva | 2 | 214 | 85 | 69 | •••@bper.ch | 58 818••• | In the CSV |
| 13 | Bayern Kapital | Venture capital firm | Landshut, Germany | Health care, Artificial intelligence | mbiomics, SPiNE, Driveblocks | 4 | 294 | 41 | 41 | •••@bayernkapital.de | +49871••• | In the CSV |
| 14 | Octopus Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Living Optics, Metris Energy, Edgify | 9 | 477 | 259 | 73 | •••@octopusvnetures.com | +44 20••• | In the CSV |
| 15 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | Biotech, Health care | smartbax, xCures, Tacalyx | 4 | 99 | 47 | 12 | +49 61••• | ||
| 16 | SFC Capital | Angel group, Micro VC fund | Northwich, United Kingdom | Fintech, Artificial intelligence | OSSTEC, Alchera Technologies, Ryft | 11 | 768 | 267 | 23 | •••@sfccapital.com | +44 20••• | In the CSV |
| 17 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | Health care, Hardware | Bioliberty, Danu Robotics, Mironid | 6 | 392 | 140 | 36 | •••@scotent.co.uk | +03000••• | In the CSV |
| 18 | Seventure Partners | Venture capital firm | Paris, France | Biotech, Health care | Microbiotica, Standing Ovation | 2 | 300 | 109 | 75 | •••@seventure.fr | +33 1-••• | In the CSV |
| 19 | Kurma Partners | Venture capital firm | Paris, France | Health care, Biotech | Tacalyx | 1 | 131 | 65 | 18 | •••@kurmapartners.com | +33184••• | In the CSV |
| 20 | BioMedPartners | Venture capital firm | Basel, Switzerland | Biotech, Health care | TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics | 87 | 29 | 22 | •••@biomedvc.com | +41 61••• | In the CSV | |
| 21 | Future Planet Capital | Venture capital firm | London, United Kingdom | Biotech, Health care | Luffy AI, Captura, CellCentric | 4 | 360 | 12 | 27 | •••@futureplanetcapital.com | +44 79••• | In the CSV |
| 22 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program, Government investment office | Lausanne, Switzerland | Health care, Biotech | Adaptyv Biosystems, Carewell, Alithea Genomics | 7 | 345 | 329 | 35 | •••@fondation-fit.ch | +41 21••• | In the CSV |
| 23 | Verve Ventures | Venture capital firm | Zug, Switzerland | Health care, Artificial intelligence | Stake, Nuclera | 2 | 275 | 37 | 35 | •••@verve.vc | In the CSV | |
| 24 | M Ventures | Corporate venture arm, Venture capital firm | Amsterdam, The Netherlands | Health care, Biotech | Polaris Electro-Optics, Quintessent, Future Fertility | 5 | 171 | 64 | 17 | In the CSV | ||
| 25 | EIC Accelerator | Startup accelerator | Brussels, Belgium | Health care, Biotech | Millow.co, D-CRBN, Omegga GmbH | 7 | 543 | 517 | 11 | In the CSV | ||
| 26 | Innosuisse | Government investment office | Berne, Switzerland | Health care, Biotech | UniSieve, KEMARO AG, Seprify | 6 | 232 | 184 | 13 | •••@innosuisse.ch | +41 58••• | In the CSV |
| 27 | Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | Health care, Artificial intelligence | Fractile, Quantrol Ox, Salience Labs | 7 | 186 | 76 | 15 | •••@oxfordsciences.com | 01865 ••• | In the CSV |
| 28 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | Fintech, Health care | Kaiko, Sonosemi Medical, Exponent Energy | 8 | 552 | 236 | 134 | +91 80••• | In the CSV | |
| 29 | Wellington Partners | Venture capital firm | Munich, Germany | Health care, Biotech | nyra health | 1 | 252 | 80 | 65 | •••@wellington-partners.com | +44 20••• | In the CSV |
| 30 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | Biotech, Artificial intelligence | Treeless, Perovskia, SolidWatts | 5 | 227 | 219 | 2 | In the CSV |
Table 2. Biotech investors in Europe: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 283.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Innovate UK | Swindon, United Kingdom | 27 | 163 | Bioliberty, Concretene, Doctoria LTD |
| 2 | Bpifrance | Maisons-alfort, France | 19 | 344 | WORMSENSING, CarbonFarm Technology, Archeon |
| 3 | European Innovation Council | Brussels, Belgium | 17 | 106 | Onego Bio, Quantrol Ox, Cellbox Solutions |
| 4 | HTGF (High-Tech Gruenderfonds) | Bonn, Germany | 17 | 257 | Rabot Energy, CereGate, syte |
| 5 | Kima Ventures | Paris, France | 16 | 325 | Topo.io, Rayon, Kelvin |
| 6 | Seedcamp | London, United Kingdom | 15 | 203 | Metaview, Flow Engineering, Rayon |
| 7 | Venture Kick | Schlieren, Switzerland | 13 | 129 | UniSieve, Cotierra, Jaipur Robotics |
| 8 | SFC Capital | Northwich, United Kingdom | 11 | 185 | OSSTEC, Alchera Technologies, Ryft |
| 9 | Parkwalk Advisors | London, United Kingdom | 10 | 38 | OSSTEC, Adsilico, Reclinker |
| 10 | Octopus Ventures | London, United Kingdom | 9 | 122 | Living Optics, Metris Energy, Edgify |
| 11 | Picus Capital | Munich, Germany | 8 | 69 | Reflex, Baselayer, FINN |
| 12 | Tiny Supercomputer Investment Company | London, United Kingdom | 8 | 64 | Zero, Neuphonic, bunch |
| 13 | Eight Roads Ventures | London, United Kingdom | 8 | 106 | Kaiko, Sonosemi Medical, Exponent Energy |
| 14 | BlueYard Capital | Berlin, Germany | 7 | 25 | Zafrens, Castelion, Transcripta Bio |
| 15 | Oxford Science Enterprises | Oxford, United Kingdom | 7 | 25 | Fractile, Quantrol Ox, Salience Labs |
Table 3. Biotech investors in Europe: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Cambridge Innovation Capital, Sofinnova Partners, University of Cambridge Enterprise | 51 to 100 | 2022 |
| Saidot | Saidot provides a platform that helps organisations manage AI risk, compliance, and policy. | Artificial intelligence | Helsinki, Finland | Seed | $1.8M | 2026-11-05 | $1.8M | Business Finland | 11 to 50 | 2018 |
| bit.bio | Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. | Biotech | Cambridge, United Kingdom | Series D | $25.0M | 2026-11-04 | $250.0M | Metaplanet | 101 to 250 | 2016 |
| Takenos | Takenos offers a digital wallet that lets users receive, send, manage, and spend international money. | Fintech | Buenos Aires, Argentina | Seed | $7.0M | 2026-11-04 | $12.2M | Outlier Ventures | 11 to 50 | 2022 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors | 11 to 50 | 2021 |
| Zafrens | Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. | Biotech | San Diego, United States | Series A | $6.0M | 2026-11-03 | $35.0M | BlueYard Capital | 11 to 50 | 2022 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh, United Kingdom | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Eos, Scottish Enterprise +1 | 11 to 50 | 2020 |
| Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Oxford Science Enterprises, Kindred Capital | 101 to 250 | 2022 |
| Opentrons Unicorn | Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. | Artificial intelligence | Long Island City, United States | Series E | $40.0M | 2026-10-29 | $300.2M | SoftBank Vision Fund | 251 to 500 | 2014 |
| Reflex | Reflex is an open-source Python framework for building and deploying web applications. | Software | San Francisco, United States | Series A | $14.0M | 2026-10-29 | $19.5M | Picus Capital | 11 to 50 | 2023 |
Table 4. Biotech investors in Europe: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 4,469 | 73% |
| Artificial intelligence | 1,343 | 22% |
| Health care | 1,022 | 17% |
| Fintech | 996 | 16% |
| Hardware | 964 | 16% |
| Biotech | 706 | 12% |
| Commerce | 560 | 9% |
| Education | 268 | 4% |
| Cybersecurity | 258 | 4% |
| Energy | 192 | 3% |
Table 5. Biotech investors in Europe: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 251 | 89% |
| Seed investors | 216 | 76% |
| Late stage investors | 125 | 44% |
| Venture investors | 124 | 44% |
| Private equity investors | 47 | 17% |
| Convertible note investors | 32 | 11% |
| Debt investors | 26 | 9% |
| Grant makers | 26 | 9% |
Table 6. Biotech investors in Europe by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Investors | Share |
|---|---|---|
| United Kingdom | 68 | 24% |
| Germany | 60 | 21% |
| Switzerland | 32 | 11% |
| France | 23 | 8% |
| Belgium | 20 | 7% |
| The Netherlands | 14 | 5% |
| Sweden | 11 | 4% |
| Denmark | 8 | 3% |
| Finland | 8 | 3% |
| Spain | 7 | 2% |
| Italy | 7 | 2% |
| Luxembourg | 6 | 2% |
Table 7. Biotech investors in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 8. Biotech investors in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 19 | 7% |
| 2010s | 108 | 39% |
| 2000s | 74 | 27% |
| 1990s | 38 | 14% |
| 1980s | 13 | 5% |
| 1970s | 5 | 2% |
Table 9. Biotech investors in Europe by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Europe. On 16 November 2026 that is 283 investors.
- 209 rows carry an email address and 174 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 283 rows: 1 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Europe are on the list?
- 283, in the file dated 16 November 2026. 189 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 209 of the 283 carry an email address in the download and 174 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 283 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 283 rows, 209 firm email addresses and 174 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 158 of the 209 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.